No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database
Catherine Tsai, Alexandra Mueller, Johannes Maubach, Rene Warschkow, Daniel P Nussbaum, Bruno Schmied, Dan Blazer, Beat Gloor & Mathias Worni
abstract |
INTRODUCTION METHODS RESULTS NAC or NACRT yield the same survival outcome for patients with resectable gastric cardia cancer. These data support the need for randomized controlled trials comparing the 2 regimens head-to-head. |
citation | Tsai C, Mueller A, Maubach J, Warschkow R, Nussbaum D P, Schmied B, Blazer D, Gloor B, Worni M. No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database. Dig Surg 2019;1-9. |
type | journal paper/review (English) |
date of publishing | 24-07-2019 |
journal title | Dig Surg |
ISSN electronic | 1421-9883 |
pages | 1-9 |
PubMed | 31340206 |
DOI | 10.1159/000501678 |